{ "items": [ "\n\n
\n \n 5 December 2022\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nContinual monitoring of genetic changes in parasite populations is a powerful tool for analysing malaria outbreaks and identifying emerging multidrug-resistant malaria strains, say researchers from NDM\u2019s Mahidol-Oxford Tropical Medicine Research Unit (MORU).
\n \n\n\n \n 2 December 2022\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nThe study from the Worldwide Antimalarial Resistance Network (WWARN) provides compelling evidence that artemether-lumefantrine should now replace quinine as the treatment of choice in the first trimester.
\n \n\n\n \n 1 December 2022\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n\n \n\n\n
\n \n\n \n \n \nThe inauguration of a new joint Shoklo Malaria Research Unit (SMRU) and Borderland Health Foundation (BHF) Building took place in Mae Ramat, Thailand, this week.
\n \n\n\n \n 28 November 2022\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Nuffield Department of Medicine and the University of Navarra have entered into a Memorandum of Understanding for collaboration on research and to apply new immunotherapy techniques to cancer patients.
\n \n\n\n \n 25 November 2022\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Leedham Lab at the Wellcome Centre for Human Genetics in the Nuffield Department of Medicine (NDM) has been awarded over \u00a32m from Cancer Research UK to develop a new tool that could help guide how bowel cancer patients are treated in the future.
\n \n\n\n \n 22 November 2022\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nData showing 7.7 million deaths from 33 bacterial infections can guide measures to strengthen health systems, particularly in low-income settings
\n \n\n\n \n 17 November 2022\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nA vaccine developed by the Oxford Vaccine Group\u2019s Prof Teresa Lambe and supported in clinical trials and manufacture scale-up by researchers from Nuffield Department of Medicine's Jenner Institute has been recommended for inclusion in a ring vaccination trial to combat a Sudan ebolavirus outbreak in Uganda.
\n \n\n\n \n 8 November 2022\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers from the Nuffield Department of Medicine\u2019s Jenner Institute have today reported the findings from a study investigating whether previously identified correlates of protection associated with the risk of tuberculosis (TB) disease could also be associated with the risk of infection from the bacteria that causes TB.
\n \n\n\n \n 4 November 2022\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nA phase I/IIa clinical trial that the Nuffield Department of Medicine's Jenner Institute collaborated on has demonstrated that a T-cell therapeutic HIV vaccine was associated with better control of the virus rebound when antiretroviral therapy (ART) was temporarily withdrawn.
\n \n\n\n \n 25 October 2022\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nEstablished in 1998, the Academy of Medical Sciences is one of the four UK National Academies, coordinating scholarly research activities and standards in the UK.
\n \n\n\n \n 24 October 2022\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n\n \n\n\n
\n \n\n \n \n \nThe UK\u2019s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium working together to develop better diagnostic tests, identify potential therapies and study vaccine effectiveness.
\n \n\n\n \n 19 October 2022\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nHealth and care research in Oxford is to receive \u00a3122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients. The funding was awarded to the two NIHR Biomedical Research Centres.
\n \n\n\n \n 17 October 2022\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers from the Nuffield Department of Medicine have today reported new findings from a study exploring how certain genes can help generate a strong immune response following vaccination with two commonly used COVID-19 vaccines \u2013 identifying a particular gene associated with a high antibody response.
\n \n\n\n \n 14 October 2022\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n\n \n\n\n
\n \n\n \n \n \nAccepting its first students in in October 2023, the Postgraduate Diploma in Global Health Research is specifically targeted at researchers and clinicians in low income countries, and will offer accessibility never previously available.
\n \n\n\n \n 13 October 2022\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nA new study found viral monkeypox DNA on multiple surfaces, personal protective equipment, and in air samples in hospital isolation rooms. For some of the samples, the viral particles were capable of replicating and therefore could potentially infect other people.
\n \n\n\n \n 12 October 2022\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nA University of Oxford team has been awarded a grant to study one of the major unsolved questions about asthma \u2013 why women are more likely to have it than men and why they are twice as likely to die from it.
\n \n\n\n \n 4 October 2022\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nTo investigate whether the symptoms of \u2018long-COVID\u2019 are associated with any long-term damage that reduces the function of the lungs and respiratory system, a study led by University of Oxford researchers used a novel computational approach to assess how COVID-19 may affect long-term lung function.
\n \n\n\n \n 8 September 2022\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers from the NDM's Jenner Institute and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of the candidate malaria vaccine, R21/Matrix-M\u2122 \u2013 which previously demonstrated high-level efficacy of 77% over the following 12 months in young west African children in 2021.
\n \n\n\n \n 6 September 2022\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers in Oxford have launched the first UK study in the general population to test for early markers of type 1 diabetes before children develop symptoms or need insulin.
\n \n\n\n \n 1 September 2022\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nFollowing on from the tragic death of Dr Ling Felce at the Plain roundabout in March 2022, the CAMS-Oxford Institute within the Nuffield Department of Medicine are seeking funds to start an award in her memory.
\n \n\n